返回
Akeso, Inc.（AKESF）价格
AKESF 股价走势图
AKESF 收益
Akeso, Inc.
$15.47
-0.19%
$-0.02
收盘价：Jan 16, 16:00:00 GMT-5
$15.55
0.51%
$0.08
盘后：Jan 16, 20:00:00 GMT-5
关键数据
前收盘价
$15.5
开盘价
$15.53
当日区间
$15.47 - $16.1
52周范围
$6.81 - $23.15
交易量
--
平均成交量
1.1K
每股收益（TTM）
-0.14
股息收益率
--
市值
$14.3B
什么是 AKESO INC.？
Akeso, Inc. Is an investment company, which engages in the research and development, production, and sale of biopharmaceuticals products. The company is headquartered in Zhongshan, Guangdong and currently employs 3,529 full-time employees. The company went IPO on 2020-04-24. The Company’s programs covering the therapeutic areas of oncology, autoimmune and metabolic diseases. The firm's products mainly include cadonilimab (PD-1/CTLA-4), ivonescimab (PD-1/VEGF), Ligufalimab (AK117, CD47), Pulocimab (AK109, VEGFR-2), ANNIKO (penpulimab, PD-1), and tagitanlimab (PD-L1) used in oncology fields as well as ebronucimab (PCSK9), ebdarokimab (IL-12/IL-23), and Gumokimab (AK111, IL-17) used in metabolic and autoimmune therapeutic fields.